What is the optimal therapy for BRAF mutant metastatic colorectal cancer?
In this presentation from the Great Debates in Gastrointestinal Malignancies 2018 conference, Dr. Scott Kopets discusses the optimal therapy for BRAF mutant colorectal cancer (CRC).
Earn CME Credit for a related activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=GDUGI2018KI
© 2018 Imedex, LLC.
Видео What is the optimal therapy for BRAF mutant metastatic colorectal cancer? канала ImedexCME
Earn CME Credit for a related activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=GDUGI2018KI
© 2018 Imedex, LLC.
Видео What is the optimal therapy for BRAF mutant metastatic colorectal cancer? канала ImedexCME
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
How to Approach the Patient With BRAF Mutant TumorBiomarkers for treatment selection in colon cancerNovel Agents and Targets in Colorectal CancerHow to do MSI testing?Should MSI be determined in all patients with stage II and III colon cancer patients?BRAF mutation – What does it mean? What are the complications of BRAF Inhibitors?BEACON Trial: Triplet Therapy in BRAF V600E–Mutated mCRCHow to approach the patient with a BRAF mutant tumorMolecular Testing in Colorectal CancerMicrosatellite Instability Status in Colorectal CancerBRAF Mutations in Colorectal CancerSignificance of MSI Status and TMB in Metastatic CRCUtilizing Radiofrequency Ablation to Treat Metastatic Bone Disease: A Case-Based PresentationColorectal Cancer: MSI Testing to All Patients and How to TestMSI in CRC – Microsatellite instability in colorectal cancer–Please participate in our survey below!Ras Raf MAPK Pathway and Cancer | Mutations, Cancer Pathogenesis, and ChemotherapyWnt/β-Catenin Signaling Pathway | Overview, Purpose and APC MutationsColorectal Cancer - OverviewAdvances in Anti-Cytokine Therapy for IBD: The Role of IL-12/23 and IL-23 InhibitorsCutaneous Manifestations of COVID-19: Identifying and Distinguishing from Pressure Injuries